Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harbin Yizhou Pharmaceutical is a Chinese pharmaceutical company based in Harbin, Heilongjiang Province, specializing in the development and manufacture of Traditional Chinese Medicine (TCM) and chemical drugs. The company's product portfolio includes a variety of dosage forms such as oral liquids, tablets, and capsules, primarily serving the domestic market. Key therapeutic areas of focus include hepatology, hematology, and nutritional health, with flagship products like Yinzhihuang Oral Liquid for liver disorders and Compound Ferrous Sulfate for anemia. Harbin Yizhou operates under strict Good Manufacturing Practice (GMP) standards to ensure the quality of its diverse range of healthcare products. The company is recognized as a significant regional player in the Northeast China pharmaceutical sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harbin Yizhou Pharmaceutical.